EHA Taskforce on Diversity, Equity, and Inclusion

The Diversity, Equity, and Inclusion Taskforce has a mandate from the EHA Board to develop a policy on Diversity, Equity, and Inclusion that will be the blueprint for:

Initiating and implementing activities to empower underrepresented groups.

Publications

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry
Aiello TF, Salmanton-Garcia J, Marchesi F, et al. Haematologica. 2024 Aug 1;109(8):2693-2700.

Master Class mentors

EHA-HKSH Hematology Tutorial

EHA is joining the Hong Kong Society of Hematology (HKSH) to organize the EHA-HKSH Hematology Tutorial on Lymphoid Malignancies.

Meeting Program

EHA-HKSH Hematology Tutorial 2025



…

Faculty information

We are honored that you have agreed to be part of the faculty for the EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary Acute Myeloid Leukemias, to be held on April 25-26, 2025, in Berlin, Germany.…

Presentations

EHA-GBMTA-AHA Hematology Tutorial

Session 1: Indolent Non-Hodgkin Lymphoma

Lecture: M Gomes da Silva 
Clinical Case: M Kurtsadze 
Self-assessment Cases: M Gomes da Silva 
Session 2: Aggressive Non-Hodgkin Lymphoma

Lecture: K Polgárová
Clinical Case: G Saghumyan
Self-assessment Cases: K Polgárová
Session 3: Myeloproliferative neoplasms (MPN)

Lecture: P Harrington
Clinical Case: K Meliksetyan
Self-assessment Cases: P Harrington
Session 4: Hodgkin Disease

Lecture: I Aurer
Clinical Case: M Zarandia 
Self-assessment…

Faculty information

We are honored that you have agreed to be part of the faculty for the EHA-HKSH Hematology Tutorial on Lymphoid Malignancies, to be held on April 5-6, 2025 in Hong Kong.

Terms & Conditions